Tesamorelin 10mg – High-Purity Research Peptide

Tesamorelin is a synthetic, modified analogue of growth hormone-releasing hormone (GHRH) designed to stimulate GHRH receptor activity in research models. In preclinical and laboratory studies it has been explored for its interaction with endogenous growth hormone release, IGF-1 signalling and metabolic regulation, and is commonly investigated in endocrine, metabolic and cellular signalling research.

Supplied as a lyophilised powder to maintain long-term stability. In laboratory settings it may be reconstituted using bacteriostatic water or another suitable solvent in accordance with established research protocols. The peptide is water-soluble and should be gently swirled to dissolve; avoid vigorous shaking.

Store unopened vials in a sealed container in a cool, dark and dry environment, protected from light and moisture.

After reconstitution, store at 2–8°C. For extended storage, aliquot and freeze at −20°C, avoiding repeated freeze–thaw cycles.

Preclinical and laboratory investigations have explored Tesamorelin in relation to several biological pathways:

• Growth hormone signalling: interaction with GHRH receptors and downstream GH/IGF-1 signalling pathways.
• Metabolic regulation: lipid metabolism, glucose signalling and energy-balance research models.
• Endocrine function: pituitary signalling and hormonal regulation pathways.
• Cellular recovery & protein synthesis models: anabolic signalling and cellular repair mechanisms.

This product is supplied strictly for laboratory research purposes. It is not a medicine, supplement or cosmetic, and is not for human or animal use.